In lesions associated with AD and psoriasis, elevated IL-17D activates the CD93-p38 MAPK/Akt/Smad2/3 pathway, resulting in the downregulation of DEAD-box helicase 5 (DDX5) expression in keratinocytes. Here, DDX5 is linked to psoriasis.